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○  Patient/Population – Patients over the age of 50 years old 
○  Intervention – Vitamin D supplementation 
○  Comparison – No supplementation  
○  Outcome – Preventing bone fractures/osteoporosis  
 
In patients ages 50 and older with vitamin D deficiency, is vitamin D 





Vitamin D is a fat soluble vitamin important for bone health as it promotes calcium 
absorption, maintains serum calcium and phosphate levels, and enables for normal bone 
mineralization. The current issue surrounding the screening for vitamin D deficiency focuses on 
a lack of accepted standards for classification and assessment.  Little evidence is available as 
to when is the appropriate time to begin screening for vitamin D deficiency and if the long term 
effects of supplementation are beneficial.  Vitamin D deficiency is classified differently 
depending on the organization and the lack of continuity is cause for confusion on who to 
screen and when to supplement.  Low vitamin D levels are associated with increased risk for 
bone loss and fractures.  The purpose of this review is to determine if supplementation of 
vitamin D is beneficial in preventing fractures and/or osteoporosis.   
 
The summation of our investigation into vitamin D deficiency and presence of musculoskeletal 
fractures has proven to be relatively inconclusive.  The resulting data from our three studies did 
not provide any definitive proof that increased vitamin D levels creates significantly better bone 
health.  We do believe there is a positive association between higher doses of vitamin D, with or 
without calcium, and better bone integrity versus lower doses of vitamin D, with or without 
calcium.  There is an upcoming clinical trial scheduled to begin in January of 2016 titled “Effects 
of Vit D Fortification on Vit D Metabolite Profiles and Status in Vit D Insufficient Individuals” (ID# - 
NCT02422784).  Hopefully this trial will provide more conclusive evidence of the benefit of 
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Study One:  Fracture Prevention with Vitamin D Supplementation – A Meta-analysis of 
Randomized Controlled Trials. 
Objective: The objective of this study was to estimate the effectiveness of vitamin D 
supplementation to prevent fractures in adults over the age of 60 years old.  
Design:  Meta-analysis of 7 double blinded RCTs 
Results:  Results were stratified first into a hip fracture category and non-vertebral fracture 
category then into low dose or high dose category.  High dose oral vitamin D supplementation 
appears to reduce the risk of hip and any non-vertebral fractures while low dose vitamin D is not 


















Critique: This meta-analysis had an adequate sample size and pertains to the age of our target 
patient population.  This article was published in 2005 and analyzes studies that were 
performed over 10 years ago.  It also included non-english studies that may not pertain to our 
patient population because there may be different risk factors for osteoporosis and vitamin D 
deficiency in other countries. 
 
Study Two:  Calcium plus Vitamin D Supplementation and the Risk of Fractures.   
Objective: The objective of this paper was to assess the primary hypothesis that 
postmenopausal women randomly assigned to a calcium plus vitamin D supplementation group 
versus a control group would reduce the risk of fractures, specifically hip fractures or secondarily 
all fractures. 
Design:  Double blinded, randomized controlled trial consisting of 36,282 postmenopausal 
women ages 50-75 recruited from the Women’s Health Initiative (WHI) clinical trials  
Results:  The study showed that bone loss was reduced with the use of calcium w/ vitamin D 
supplementation but lacked statistical significance to reduce fractures of the hip, vertebra, lower 












Critique: Positive aspect of this article is it had a very large sample size.  However, participants 
were allowed to consume up to 1,000 mg/d of calcium and 600 IU/d of vitamin D as extra 
supplementation and it was not regulated by the trial and therefore had great risk for skewing 
data.  Like study one, this is an old study published in 2006 and was performed from 1995-2000.  
Another concern is the participants were recruited from WHI dietary modification  and hormone 
therapy trials.  Altered diet and consumption of hormones may affect the absorption of vitamin D 
and calcium.  
Table 1. Intention to Treat Analysis -- Hip Fracture Results 
HIp Fracture Relative Risk Q Test (P-value) 
Pooled Data  0.88  0.09 (Heterogeneity) 
High Dose (700-800IU/day) 
NNT = 45 
0.74 0.74 (Homogeneity) 
Low Dose (400IU/day) 1.15 0.68 (Homogeneity) 
Table 2. Intention to Treat Analysis -- Nonvertebral Fracture Results 
Nonvertebral Fracture  Relative Risk Q Test (P-Value) 
Pooled Data  0.83 0.07 (Heterogeneity)  
High Dose (700-800IU/day) 
NNT = 27 
0.77 0.41 
Low Dose (400IU/day) 1.03 0.36 
Study Three:  Treatment of Vitamin Insufficiency in Postmenopausal Women - A 
Randomized Clinical Trial  
Objective:  The objective of this research article was to investigate the effects of high and low 
dose cholecalciferol on total fractional calcium absorption, bone mineral density, and muscle 
fitness after one year in postmenopausal women with vitamin D insufficiency.   
Design:  RCT including 230 postmenopausal women ages 75 and younger recruited from local 
advertisements.  Randomized into a high dose cholecalciferol (50,000 IU/d), low dose (800 IU/
d), or placebo group.  Each group took a white capsule daily and a yellow capsule every 15th 
day depending on their specified treatment group. 
Results: Considerable variability among mean serum 25 (OH)D levels were found between low-
dose group, high-dose group and placebo group.  Total fractional calcium absorption did 
increase with high-dose group but decreased with low-dose and placebo groups.   
Critique: Small sample size (n=230) is limiting for significance of results; more recent study and 
good adherence to the study is good (100% across all arms); only recruited from Wisconsin; 




Table 3.  Rate of Fracture Summary -- Number of cases (annualized %) 
Calcium + Vitamin D Placebo Hazard Ratio (95% CI) 
Hip 175 (0.14) 199 (0.16) 0.88 (0.72-1.08) 
Clinical Vertebral 181 (0.14) 197 (0.15) 0.90 (0.74-1.10) 
Lower arm or wrist 565 (0.44) 557 (0.44) 1.01 (0.90-1.14) 
Total 2102 (1.64) 2158 (1.70) 0.96 (0.91-1.02) 
Table 4.  Overall Summary of Included Studies 
Bischoff et al Jackson et al Hansen et al 
Study 
population 
9,280 36,282 230 
Age of 
participants  
> 60 yo 50-79 yo < 75 yo 
Calcium admin 4 @ 500-1,200 mg/day 
3 @ 800 mg/day 
1,000 mg/day 600-1,400 mg/day 
Vitamin D 
admin  
2 @ 400 IU/day 
5 @ 700-800 IU/day 
400 IU/day Low dose – 800 IU/day 








2 yr 7 yr avg 1 yr 
Compliance N/A ~67% nearly 100% 
Figure 1.  Vitamin D Metabolism retreived from http://plantbaseddietitian.com/tag/bone-metabolism/ 
